Rallybio (RLYB) Equity Average (2023 - 2025)
Historic Equity Average for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $54.5 million.
- Rallybio's Equity Average fell 2773.69% to $54.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.5 million, marking a year-over-year decrease of 2773.69%. This contributed to the annual value of $83.9 million for FY2024, which is N/A changed from last year.
- Latest data reveals that Rallybio reported Equity Average of $54.5 million as of Q3 2025, which was down 2773.69% from $50.0 million recorded in Q2 2025.
- In the past 5 years, Rallybio's Equity Average registered a high of $147.2 million during Q2 2023, and its lowest value of $50.0 million during Q2 2025.
- Moreover, its 3-year median value for Equity Average was $80.0 million (2024), whereas its average is $88.0 million.
- As far as peak fluctuations go, Rallybio's Equity Average tumbled by 4261.29% in 2024, and later crashed by 2773.69% in 2025.
- Quarter analysis of 3 years shows Rallybio's Equity Average stood at $114.9 million in 2023, then tumbled by 42.34% to $66.2 million in 2024, then fell by 17.72% to $54.5 million in 2025.
- Its last three reported values are $54.5 million in Q3 2025, $50.0 million for Q2 2025, and $57.9 million during Q1 2025.